The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...